SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 18th, 2023 • Galmed Pharmaceuticals Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 14, 2023, between Galmed Pharmaceuticals, a company incorporated under the laws of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
WARRANT TO PURCHASE ORDINARY SHARES GALMED PHARMACEUTICALS LTD.Galmed Pharmaceuticals Ltd. • July 18th, 2023 • Pharmaceutical preparations • New York
THIS WARRANT TO PURCHASE ORDINARY SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _______, 20__ (the “Termination Date”) but not thereafter, to subscribe for and purchase from Galmed Pharmaceuticals Ltd., a company incorporated under the laws of Israel (the “Company”), up to ______ ordinary shares, par value NIS 0.15 per share (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one ordinary share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole regist
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • July 18th, 2023 • Galmed Pharmaceuticals Ltd. • Pharmaceutical preparations • New York
